Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Aug;42(2):319–325. doi: 10.1038/bjc.1980.233

Sequential biochemical and histological changes in rats treated with aflatoxin B1.

S J Yin, M C Kao, S C Lee
PMCID: PMC2010393  PMID: 7426338

Abstract

Thirteen biochemical parameters (viz. glucose, calcium, inorganic phosphorous, urea nitrogen, uric acid, cholesterol, albumin, total protein, total bilirubin, alkaline phosphatase, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase) were determined in serum and partly in liver of rats 1-28 days after i.p. aflatoxin B1 (AFB) (3 mg/kg). Histological examinations of the liver were also made in parallel to the biochemical studies. In the serum, enzyme activities and total bilirubin level increased and peaked on the 2nd day, while other activities of aspartate aminotransferase and alanine aminotransferase in the liver significantly decreased and reached a minimum on the 2nd day after AFB administration. The depression of the liver enzyme activities persisted over 7 days. The liver protein content also reduced transiently during 1-1.5 days. However, all biochemical parameters returned to normal levels 2 weeks after treatment, and remained so throughout the rest of experimental period. Histological changes in the liver were very similar to those reported by other.

Full text

PDF
319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akinrimisi E. O., Benecke B. J., Seifart K. H. Inhibition of rat-liver RNA polymerase in vitro by aflatoxin B1 in the presence of microsomal fraction. Eur J Biochem. 1974 Mar 1;42(2):333–339. doi: 10.1111/j.1432-1033.1974.tb03344.x. [DOI] [PubMed] [Google Scholar]
  2. BUTLER W. H. ACUTE TOXICITY OF AFLATOXIN B-1 IN RATS. Br J Cancer. 1964 Dec;18:756–762. doi: 10.1038/bjc.1964.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bowers G. N., Jr, McComb R. B. Measurement of total alkaline phosphatase activity in human serum. Clin Chem. 1975 Dec;21(13):1988–1995. [PubMed] [Google Scholar]
  4. Campbell T. C., Hayes J. R. The role of aflatoxin metabolism in its toxic lesion. Toxicol Appl Pharmacol. 1976 Feb;35(2):199–222. doi: 10.1016/0041-008x(76)90282-9. [DOI] [PubMed] [Google Scholar]
  5. Croy R. G., Essigmann J. M., Reinhold V. N., Wogan G. N. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1745–1749. doi: 10.1073/pnas.75.4.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Essigmann J. M., Croy R. G., Nadzan A. M., Busby W. F., Jr, Reinhold V. N., Büchi G., Wogan G. N. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci U S A. 1977 May;74(5):1870–1874. doi: 10.1073/pnas.74.5.1870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lin J. K., Miller J. A., Miller E. C. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 1977 Dec;37(12):4430–4438. [PubMed] [Google Scholar]
  8. Martin C. N., Garner R. C. Aflatoxin B -oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids. Nature. 1977 Jun 30;267(5614):863–865. doi: 10.1038/267863a0. [DOI] [PubMed] [Google Scholar]
  9. Morin L. G. Improved stable diazonium salt procedure for determination of total serum bilirubin. Clin Chim Acta. 1973 Aug 17;47(1):111–112. doi: 10.1016/0009-8981(73)90067-3. [DOI] [PubMed] [Google Scholar]
  10. Pai M. R., Bai N. J., Venkitasubramanian T. A. Aflatoxin induced inhibition of protein synthesis. Toxicon. 1978;16(3):283–287. doi: 10.1016/0041-0101(78)90089-2. [DOI] [PubMed] [Google Scholar]
  11. Peers F. G., Gilman G. A., Linsell C. A. Dietary aflatoxins and human liver cancer. A study in Swaziland. Int J Cancer. 1976 Feb 15;17(2):167–176. doi: 10.1002/ijc.2910170204. [DOI] [PubMed] [Google Scholar]
  12. REES K. R., SINHA K. P. Blood enzymes in liver injury. J Pathol Bacteriol. 1960 Oct;80:297–307. [PubMed] [Google Scholar]
  13. Stora C., Aussel C., Mayzaud O., Masseyeff R. Hepatocarcinogenesis by aflatoxin B1: relationships between the cellular localization of the carcinogen and early histological changes in the rat liver. Biomedicine. 1979 Oct;31(6):173–176. [PubMed] [Google Scholar]
  14. Stora C. Cellular localization of chemical carcinogens studied by fluorescence microscopy. Oncology. 1980;37(1):20–22. doi: 10.1159/000225394. [DOI] [PubMed] [Google Scholar]
  15. Svoboda D., Grady H. J., Higginson J. Aflatoxin B1 injury in rat and monkey liver. Am J Pathol. 1966 Dec;49(6):1023–1051. [PMC free article] [PubMed] [Google Scholar]
  16. Swenson D. H., Lin J. K., Miller E. C., Miller J. A. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res. 1977 Jan;37(1):172–181. [PubMed] [Google Scholar]
  17. Unger P. D., Mehendale H. M., Hayes A. W. Hepatic uptake and disposition of aflatoxin B1 in isolated perfused rat liver. Toxicol Appl Pharmacol. 1977 Sep;41(3):523–534. doi: 10.1016/s0041-008x(77)80007-0. [DOI] [PubMed] [Google Scholar]
  18. Villa-Treviño S., Leaver D. D. Effects of the hepatotoxic agents retrorsine and aflatoxin B1 on hepatic protein synthesis in the rat. Biochem J. 1968 Aug;109(1):87–91. doi: 10.1042/bj1090087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wogan G. N. Biochemical responses to aflatoxins. Cancer Res. 1968 Nov;28(11):2282–2287. [PubMed] [Google Scholar]
  20. Wogan G. N., Edwards G. S., Shank R. C. Excretion and tissue distribution of radioactivity from aflatoxin B1-14-C in rats. Cancer Res. 1967 Oct;27(10):1729–1736. [PubMed] [Google Scholar]
  21. Wogan G. N., Friedman M. A. Inhibition by aflatonin B-1 of hydrocortisone induction of rat liver tryptophan pyrrolase and tyrosine transaminase. Arch Biochem Biophys. 1968 Nov;128(2):509–516. doi: 10.1016/0003-9861(68)90058-1. [DOI] [PubMed] [Google Scholar]
  22. Wogan G. N., Newberne P. M. Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res. 1967 Dec;27(12):2370–2376. [PubMed] [Google Scholar]
  23. Yu F. L. Mechanism of aflatoxin B1 inhibition of rat hepatic nuclear RNA synthesis. J Biol Chem. 1977 May 25;252(10):3245–3251. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES